Skip to main content

Table 2 Genomic Signatures Included in the Study

From: Nomogram integrating gene expression signatures with clinicopathological features to predict survival in operable NSCLC: a pooled analysis of 2164 patients

Functional class

Signature name

Year

Number of genes mapped onto the platforms

Patients with the signature classified as (%)a

Reference

GPL570

GPL96

Presence

Uncertainty

Absence

Prognosis

Combined prognostic classifier

2006

91

90

370 (27.9)

547 (41.3)

409 (30.8)

[28]

Prognosis

Non-overlapping signature

2008

86

85

393 (29.6)

532 (40.1)

401 (30.2)

[29]

Prognosis

Robust gene signature

2011

58

57

467 (35.2)

358 (27.0)

501 (37.8)

[30]

Prognosis

Poor survival signature

2006

61

60

330 (24.9)

577 (43.5)

419 (31.6)

[31]

Prognosis

72-gene classifier

2009

59

47

429 (32.4)

437 (33.0)

460 (34.7)

[32]

Prognosis

Recurrence signature

2011

43

43

253 (19.1)

814 (61.4)

259 (19.5)

[33]

Biology/microenvironment

CIN70 signature

2006

70

66

609 (45.9)

151 (11.4)

566 (42.7)

[12]

Biology/microenvironment

Cell cycle signature

2002

729

601

599 (45.2)

112 (8.4)

615 (46.4)

[34]

Biology/microenvironment

Hypoxia signature

2006

141

117

504 (38.0)

323 (24.4)

499 (37.6)

[13]

Biology/microenvironment

Malignancy-risk signature

2011

91

91

547 (41.3)

644 (48.6)

135 (10.2)

[35]

Biology/microenvironment

Invasiveness gene signature

2007

172

128

315 (23.8)

798 (60.2)

213 (16.1)

[36]

Biology/microenvironment

Wound signature

2004

411

348

459 (34.6)

486 (36.7)

381 (28.7)

[14]

Biology/microenvironment

Metastatic signature

2002

115

112

214 (16.1)

1042 (78.6)

70 (5.3)

[15]

Biology/microenvironment

Metabolism proteome signature

2014

194

187

412 (31.1)

586 (44.2)

328 (24.7)

[37]

Biology/microenvironment

Hypoxia metagene

2007

142

123

378 (28.5)

538 (40.6)

410 (30.9)

[38]

Biology/microenvironment

CAFs signature

2011

45

34

176 (13.3)

1074 (81.0)

76 (5.7)

[39]

Biology/microenvironment

HRD signature

2014

217

182

208 (15.7)

590 (44.5)

528 (39.8)

[16]

Biology/microenvironment

Lactic acidosis response signature

2008

1770

1378

415 (31.3)

463 (34.9)

448 (33.8)

[17]

Biology/microenvironment

Angiogenesis signature

2013

477

399

505 (38.1)

573 (43.2)

248 (18.7)

[40]

Biology/microenvironment

Angiogenic signature

2005

58

56

215 (16.2)

928 (70.0)

183 (13.8)

[41]

Pathway

PTEN signature

2007

177

156

459 (34.6)

688 (51.9)

179 (13.5)

[18]

Pathway

TGF-β signature

2008

240

212

161 (12.1)

1042 (78.6)

123 (9.3)

[19]

Pathway

Ras signature

2006

252

203

321 (24.2)

869 (65.5)

136 (10.3)

[42]

Pathway

Myc signature

2006

194

159

348 (26.2)

712 (53.7)

266 (20.1)

[42]

Pathway

E2F3 signature

2006

241

183

149 (11.2)

1129 (85.1)

48 (3.6)

[42]

Pathway

β-catenin signature

2006

76

70

8 (0.6)

1291 (97.4)

27 (2.0)

[42]

Pathway

Src signature

2006

63

57

17 (1.3)

1280 (96.5)

29 (2.2)

[42]

  1. aSamples were classified as presence, absence or uncertainty by respective published genomic signatures based on prediction result (false discover rate [FDR] <0.05) of Nearest Template Prediction (NTP)